Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balanced crystalloids versus balanced colloids during goal-directed fluid therapy for gynecological tumor resection
ISRCTN53154834Phase 4Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hetastarch and iopamidol in ovarian cancer (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Intra-operatively administered amount of intravenous fluids. Started May 2009; status: completed.
02
Drugs
hetastarchiopamidol
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on ISRCTN53154834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN53154834.